Improving access to and utilization of the healthcare system may benefit African-American prostate cancer patients more than educational or motivational interventions, according to a new study.
Decreasing the rates of prostate cancer among black men may require improving access to routine health care, rather than increased education about the disease, a study from the University of North Carolina at Chapel Hill School of Medicine suggests.
Among the drugs that will be discussed in Amsterdam over the next three days are bevacizumab, cetuximab, dasatinib, erlotinib, lapatinib, nilotinib, oblimersen sodium, sorafenib, and sunitinib.
The Prostate Cancer Foundation (PCF) announced today that John A. Martignetti, of Mount Sinai School of Medicine’s Department of Genetics And Genomic Sciences, is a recipient of one of the 2006 Competitive Awards Program grants. Sixty-three research investigators from four countries received a total of $6.1 million in awards.
Scientists at the Wellcome Trust Sanger Institute, where one-third of the human genome was sequenced, have now pioneered decoding the sequence of cancer genomes. They have carried out the broadest survey yet of the human genome in cancer by sequencing more than 250 million letters of DNA code, covering more than 500 genes and 200 cancers.
Two researchers from the University Hospital and the Center for Applied Medical Research (CIMA) from the University of Navarra have published an article in Nature Cancer Reviews.
Long-term, high-level exposure to bacterial endotoxin — a contaminant found in raw cotton fiber and cotton dust — is associated with a 40 percent decrease in lung cancer risk among female Chinese textile workers, according to a new study in the March 7 Journal of the National Cancer Institute.
The first report of an international study looking at computed tomography (CT) to screen current or former smokers for lung cancer found that screening did not reduce deaths from lung cancer.
Screening current or former smokers with the imaging technique of computed tomography may increase the rate of diagnosis and treatment of lung cancer, but may not necessarily reduce the risk of advanced lung cancer or death from lung cancer, according to a study in the March 7 issue of JAMA.
In experiments with laboratory mice that bearaggressive human breast cancers, UC Davis researchers have used hotnanoprobes to slow the growth of tumors — without damage to surroundinghealthy tissue. The researchers describe their work in the March issue ofthe Journal of Nuclear Medicine.